Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine

Stacie J Fairley, Shree R Singh, Abebayehu N Yilma, Alain B Waffo, Praseetha Subbarayan, Saurabh Dixit, Murtada A Taha, Chino D Cambridge, Vida A Dennis Center for NanoBiotechnology Research, Alabama State University, Montgomery, AL, USA Abstract: We recently demonstrated by in vitro experiments tha...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fairley SJ, Singh SR, Yilma AN, Waffo AB, Subbarayan P, Dixit S, Taha MA, Cambridge CD, Dennis VA
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/02123a29b6334a68a0c501e58a5ba193
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:02123a29b6334a68a0c501e58a5ba193
record_format	dspace
spelling	oai:doaj.org-article:02123a29b6334a68a0c501e58a5ba1932021-12-02T05:40:29ZChlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine1176-91141178-2013https://doaj.org/article/02123a29b6334a68a0c501e58a5ba1932013-05-01T00:00:00Zhttp://www.dovepress.com/chlamydia-trachomatis-recombinant-momp-encapsulated-in-plga-nanopartic-a13201https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Stacie J Fairley, Shree R Singh, Abebayehu N Yilma, Alain B Waffo, Praseetha Subbarayan, Saurabh Dixit, Murtada A Taha, Chino D Cambridge, Vida A Dennis Center for NanoBiotechnology Research, Alabama State University, Montgomery, AL, USA Abstract: We recently demonstrated by in vitro experiments that PLGA (poly D, L-lactide-co-glycolide) potentiates T helper 1 (Th1) immune responses induced by a peptide derived from the recombinant major outer membrane protein (rMOMP) of Chlamydia trachomatis, and may be a promising vaccine delivery system. Herein we evaluated the immune-potentiating potential of PLGA by encapsulating the full-length rMOMP (PLGA-rMOMP), characterizing it in vitro, and investigating its immunogenicity in vivo. Our hypothesis was that PLGA-rMOMP triggers Th1 immune responses in mice, which are desirable prerequisites for a C. trachomatis candidate nanovaccine. Physical-structural characterizations of PLGA-rMOMP revealed its size (approximately 272 nm), zeta potential (−14.30 mV), apparent spherical smooth morphology, and continuous slow release pattern. PLGA potentiated the ability of encapsulated rMOMP to trigger production of cytokines and chemokines by mouse J774 macrophages. Flow cytometric analyses revealed that spleen cells from BALB/c mice immunized with PLGA-rMOMP had elevated numbers of CD4+ and CD8+ T cell subsets, and secreted more rMOMP-specific interferon-gamma (Th1) and interleukin (IL)-12p40 (Th1/Th17) than IL-4 and IL-10 (Th2) cytokines. PLGA-rMOMP-immunized mice produced higher serum immunoglobulin (Ig)G and IgG2a (Th1) than IgG1 (Th2) rMOMP-specific antibodies. Notably, sera from PLGA-rMOMP-immunized mice had a 64-fold higher Th1 than Th2 antibody titer, whereas mice immunized with rMOMP in Freund's adjuvant had only a four-fold higher Th1 than Th2 antibody titer, suggesting primarily induction of a Th1 antibody response in PLGA-rMOMP-immunized mice. Our data underscore PLGA as an effective delivery system for a C. trachomatis vaccine. The capacity of PLGA-rMOMP to trigger primarily Th1 immune responses in mice promotes it as a highly desirable candidate nanovaccine against C. trachomatis. Keywords: Chlamydia trachomatis, bacteria, vaccine, antibody, cytokines, PLGA nanoparticles Fairley SJSingh SRYilma ANWaffo ABSubbarayan PDixit STaha MACambridge CDDennis VADove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2013, Iss default, Pp 2085-2099 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Fairley SJ Singh SR Yilma AN Waffo AB Subbarayan P Dixit S Taha MA Cambridge CD Dennis VA Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine
description	Stacie J Fairley, Shree R Singh, Abebayehu N Yilma, Alain B Waffo, Praseetha Subbarayan, Saurabh Dixit, Murtada A Taha, Chino D Cambridge, Vida A Dennis Center for NanoBiotechnology Research, Alabama State University, Montgomery, AL, USA Abstract: We recently demonstrated by in vitro experiments that PLGA (poly D, L-lactide-co-glycolide) potentiates T helper 1 (Th1) immune responses induced by a peptide derived from the recombinant major outer membrane protein (rMOMP) of Chlamydia trachomatis, and may be a promising vaccine delivery system. Herein we evaluated the immune-potentiating potential of PLGA by encapsulating the full-length rMOMP (PLGA-rMOMP), characterizing it in vitro, and investigating its immunogenicity in vivo. Our hypothesis was that PLGA-rMOMP triggers Th1 immune responses in mice, which are desirable prerequisites for a C. trachomatis candidate nanovaccine. Physical-structural characterizations of PLGA-rMOMP revealed its size (approximately 272 nm), zeta potential (−14.30 mV), apparent spherical smooth morphology, and continuous slow release pattern. PLGA potentiated the ability of encapsulated rMOMP to trigger production of cytokines and chemokines by mouse J774 macrophages. Flow cytometric analyses revealed that spleen cells from BALB/c mice immunized with PLGA-rMOMP had elevated numbers of CD4+ and CD8+ T cell subsets, and secreted more rMOMP-specific interferon-gamma (Th1) and interleukin (IL)-12p40 (Th1/Th17) than IL-4 and IL-10 (Th2) cytokines. PLGA-rMOMP-immunized mice produced higher serum immunoglobulin (Ig)G and IgG2a (Th1) than IgG1 (Th2) rMOMP-specific antibodies. Notably, sera from PLGA-rMOMP-immunized mice had a 64-fold higher Th1 than Th2 antibody titer, whereas mice immunized with rMOMP in Freund's adjuvant had only a four-fold higher Th1 than Th2 antibody titer, suggesting primarily induction of a Th1 antibody response in PLGA-rMOMP-immunized mice. Our data underscore PLGA as an effective delivery system for a C. trachomatis vaccine. The capacity of PLGA-rMOMP to trigger primarily Th1 immune responses in mice promotes it as a highly desirable candidate nanovaccine against C. trachomatis. Keywords: Chlamydia trachomatis, bacteria, vaccine, antibody, cytokines, PLGA nanoparticles
format	article
author	Fairley SJ Singh SR Yilma AN Waffo AB Subbarayan P Dixit S Taha MA Cambridge CD Dennis VA
author_facet	Fairley SJ Singh SR Yilma AN Waffo AB Subbarayan P Dixit S Taha MA Cambridge CD Dennis VA
author_sort	Fairley SJ
title	Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine
title_short	Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine
title_full	Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine
title_fullStr	Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine
title_full_unstemmed	Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine
title_sort	chlamydia trachomatis recombinant momp encapsulated in plga nanoparticles triggers primarily t helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/02123a29b6334a68a0c501e58a5ba193
work_keys_str_mv	AT fairleysj chlamydiatrachomatisrecombinantmompencapsulatedinplgananoparticlestriggersprimarilythelper1cellularandantibodyimmuneresponsesinmiceadesirablecandidatenanovaccine AT singhsr chlamydiatrachomatisrecombinantmompencapsulatedinplgananoparticlestriggersprimarilythelper1cellularandantibodyimmuneresponsesinmiceadesirablecandidatenanovaccine AT yilmaan chlamydiatrachomatisrecombinantmompencapsulatedinplgananoparticlestriggersprimarilythelper1cellularandantibodyimmuneresponsesinmiceadesirablecandidatenanovaccine AT waffoab chlamydiatrachomatisrecombinantmompencapsulatedinplgananoparticlestriggersprimarilythelper1cellularandantibodyimmuneresponsesinmiceadesirablecandidatenanovaccine AT subbarayanp chlamydiatrachomatisrecombinantmompencapsulatedinplgananoparticlestriggersprimarilythelper1cellularandantibodyimmuneresponsesinmiceadesirablecandidatenanovaccine AT dixits chlamydiatrachomatisrecombinantmompencapsulatedinplgananoparticlestriggersprimarilythelper1cellularandantibodyimmuneresponsesinmiceadesirablecandidatenanovaccine AT tahama chlamydiatrachomatisrecombinantmompencapsulatedinplgananoparticlestriggersprimarilythelper1cellularandantibodyimmuneresponsesinmiceadesirablecandidatenanovaccine AT cambridgecd chlamydiatrachomatisrecombinantmompencapsulatedinplgananoparticlestriggersprimarilythelper1cellularandantibodyimmuneresponsesinmiceadesirablecandidatenanovaccine AT dennisva chlamydiatrachomatisrecombinantmompencapsulatedinplgananoparticlestriggersprimarilythelper1cellularandantibodyimmuneresponsesinmiceadesirablecandidatenanovaccine
_version_	1718400272672227328

Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine

Ejemplares similares